A role for inducible 6-phosphofructo-2-kinase in the control of neuronal glycolysis

Journal of Nutritional Biochemistry

Volumn 24, Issue 6, 2013, Pages 1153-1158

  Li, Honggui ^a   Guo, Xin ^a   Xu, Hang ^a   Woo, Shih Lung ^a   Halim, Vera ^a   Morgan, Caurnel ^a   Wu, Chaodong ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

AMP activated protein kinase; Glucose sensing; Glycolysis; Hypothalamus; Inducible 6 phosphofructo 2 kinase; Neuropeptide

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE; AGOUTI RELATED PROTEIN; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; MESSENGER RNA; NEUROPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN NERVE CELL; ENZYME PHOSPHORYLATION; FOOD INTAKE; GENE; GENE OVEREXPRESSION; GENETIC CODE; GLYCOLYSIS; HYPOTHALAMUS; MALE; MOUSE; NONHUMAN; PFKFB3 GENE;

AGOUTI-RELATED PROTEIN; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; EATING; ENZYME INDUCTION; GLUCOSE; GLYCOLYSIS; HYPOTHALAMUS; MALE; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NEURONS; PHOSPHOFRUCTOKINASE-2; RNA, MESSENGER;

AGOUTI;

EID: 84878014577     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.08.016     Document Type: Article

References (59)

1. Morley J.E., Hernandez E.N., Flood J.F. Neuropeptide Y increases food intake in mice. Am J Physiol Regul Integr Comp Physiol 1987, 253(3):R516-R522.
2. Rossi M., Kim M.S., Morgan D.G.A., Small C.J., Edwards C.M.B., Sunter D., et al. A C-terminal fragment of agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology 1998, 139(10):4428-4431.
3. Thim L., Kristensen P., Larsen P.J., Wulff B.S. CART, a new anorectic peptide. Int J Biochem Cell Biol 1998, 30(12):1281-1284.
4. Larsen P.J., Vrang N., Petersen P.C., Kristensen P. Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats. Obes Res 2000, 8(8):590-596.
5. Millington G.W. The role of proopiomelanocortin (POMC) neurones in feeding behaviour. Nutr Metab 2007, 4:18.
6. Andersson U., Filipsson K., Abbott C.R., Woods A., Smith K., Bloom S.R., et al. AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem 2004, 279(13):12005-12008.
7. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004, 2004(428):569-574.
8. Lee K., Li B., Xi X., Suh Y., Martin R.J. Role of neuronal energy status in the regulation of adenosine 5'-monophosphate-activated protein kinase, orexigenic neuropeptides expression, and feeding behavior. Endocrinology 2005, 146(1):3-10.
9. Namkoong C., Kim M.S., Jang P.G., Han S.M., Park H.S., Koh E.H., et al. Enhanced hypothalamic AMP-activated protein kinase activity contributes to hyperphagia in diabetic rats. Diabetes 2005, 54(1):63-68.
10. Kahn B.B., Alquier T., Carling D., Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005, 1(1):15-25.
11. Cota D., Proulx K., Seeley R.J. The role of CNS fuel sensing in energy and glucose regulation. Gastroenterology 2007, 132(6):2158-2168.
12. Mountjoy P.D., Bailey S.J., Rutter G.A. Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity. Diabetologia 2007, 50(1):168-177.
13. Kim M.S., Park J.Y., Namkoong C., Jang P.G., Ryu J.W., Song H.S., et al. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 2004, 10(7):727-733.
14. Ahima R.S., Lazar M.A. Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol 2008, 22(5):1023-1031.
15. Cheng H., Isoda F., Belsham D.D., Mobbs C.V. Inhibition of agouti-related peptide expression by glucose in a clonal hypothalamic neuronal cell line is mediated by glycolysis, not oxidative phosphorylation. Endocrinology 2008, 149(2):703-710.
16. Pilkis S.J., El-Maghrabi M.R., Claus T.H. Hormonal regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Biochem 1988, 57:755-783.
17. Nordlie R.C., Foster J.D., Lange A.J. Regulation of glucose production by the liver. Annu Rev Nutr 1999, 19:379-406.
18. Wu C., Khan S.A., Lange A.J. Regulation of glycolysis-role of insulin. Exp Gerontol 2005, 40(11):894-899.
19. 2 levels. J Biol Chem 1995, 270(41):24229-24236.
20. Wu C., Okar D.A., Newgard C.B., Lange A.J. Overexpression of 6-phosphofructo-2- kinase/fructose-2,6-bisphosphatase in mouse liver lowers blood glucose by suppression of hepatic glucose production. J Clin Invest 2001, 107(1):91-98.
21. Wu C., Kang J.E., Peng L., Li H., Khan S.A., Hillard C.J., et al. Enhancing hepatic glycolysis reduces obesity: differential effects on lipogenesis depend on site of glycolytic modulation. Cell Metab 2005, 2(2):131-140.
22. Wu C., Khan S.A., Peng L.J., Li H., Camela S., Lange A.J. Perturbation of glucose flux in the liver by decreasing fructose-2,6-bisphosphate levels causes hepatic insulin resistance and hyperglycemia. Am J Physiol Endocrinol Metab 2006, 291(3):E536-E543.
23. Atsumi T., Nishio T., Niwa H., Takeuchi J., Bando H., Shimizu C., et al. Expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase/PFKFB3 isoforms in adipocytes and their potential role in glycolytic regulation. Diabetes 2005, 54(12):3349-3357.
24. Huo Y., Guo X., Li H., Wang H., Zhang W., Wang Y., et al. Disruption of inducible 6-phosphofructo-2-kinase ameliorates diet-induced adiposity but exacerbates systemic insulin resistance and adipose tissue inflammatory response. J Biol Chem 2010, 285:3713-3721.
25. Guo X., Xu K., Zhang J., Li H., Zhang W., Wang H., et al. Involvement of inducible 6-phosphofructo-2-kinase in the anti-diabetic effect of PPARγ activation in mice. J Biol Chem 2010, 285(31):23711-23720.
26. Yang X., Kow L., Funabashi T., Mobbs C. Hypothalamic glucose sensor: similarities to and differences from pancreatic beta-cell mechanisms. Diabetes 1999, 48(9):1763-1772.
27. Lynch R.M., Tompkins L.S., Brooks H.L., Dunn-Meynell A.A., Levin B.E. Localization of glucokinase gene expression in the rat brain. Diabetes 2000, 49(5):693-700.
28. Levin B.E. Glucosensing neurons do more than just sense glucose. Int J Obes Relat Metab Disord 2001, 25(Suppl 5):S68-S72.
29. Dunn-Meynell A.A., Routh V.H., Kang L., Gaspers L., Levin B.E. Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons. Diabetes 2002, 51(7):2056-2065.
30. Kang L., Routh V.H., Kuzhikandathil E.V., Gaspers L.D., Levin B.E. Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons. Diabetes 2004, 53(3):549-559.
31. Kang L., Dunn-Meynell A.A., Routh V.H., Gaspers L.D., Nagata Y., Nishimura T., et al. Glucokinase is a critical regulator of ventromedial hypothalamic neuronal glucosensing. Diabetes 2006, 55(2):412-420.
32. Levin B.E. Metabolic sensing neurons and the control of energy homeostasis. Physiol Behav 2006, 89(4):486-489.
33. Kessler R., Eschrich K. Splice isoforms of ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in human brain. Brain Res Mol Brain Res 2001, 87(2):190-195.
34. Pilkis S.J., Walderhaug M., Murray K., Beth A., Venkataramu S.D., Pilkis G.J., et al. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase from rat liver: Isolation and. J Biol Chem 1983, 258(10):6135-6141.
35. Chikri M., Rousseau G. Rat gene coding for heart 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: characterization of an unusual promoter region and identification of four mRNAs. Biochemistry 1995, 34(27):8876-8884.
36. Sakurai T., Johnson J., Uyeda K. Islet fructose 6-phosphate, 2-kinase:fructose 2,6-bisphosphatase: isozymic form, expression, and characterization. Biochem Biophys Res Commun 1996, 218(1):159-163.
37. Watanabe G., Sakai A., Furuya E. Novel isoforms of rat brain fructose 6-phosphate 2-kinase/fructose 2,6-bisphosphatase are generated by tissue-specific alternative splicing. J Neurochem 1997, 69(1):1-9.
38. Hirata T., Kato M., Okamura N., Fukasawa M., Sakakibara R. Expression of human placental-type 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase in various cells and cell lines. Biochem Biophys Res Comm 1998, 242:680-684.
39. Chesney J., Mitchell R., Benigni F., Bacher M., Spiegel L., Al-Abed Y., et al. An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. Proc Natl Acad Sci USA 1999, 96:3047-3052.
40. Watanabe F., Furuya E. Tissue-specific alternative splicing of rat brain fructose-6 phosphate 2-kinase/fructose 2,6-bisphosphatase. FEBS Lett 1999, 458:1-5.
41. Rider M.H., Bertrand L., Vertommen D., Michels P.A., Rousseau G.G., Hue L. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. Biochem J 2004, 381(3):561-579.
42. Depre C., Rider M.H., Veitch K., Hue L. Role of fructose-2,6-bisphosphate in the control of heart glycolysis. J Biol Chem 1993, 268:13274-13279.
43. Hue L., Rider M. Role of fructose-2,6-bisphosphate in the control of glycolysis in mammalian tissues. J Biochem 1987, 245:313-325.
44. Jin E.S., Uyeda K., Kawaguchi T., Burgess S.C., Malloy C.R., Sherry A.D. Increased hepatic fructose 2,6 bisphosphate after an oral glucose load does not affect gluconeogenesis. J Biol Chem 2003, 278(31):28427-28433.
45. Donthi R.V., Ye G., Wu C., McClain D.A., Lange A.J., Epstein P.N. Cardiac expression of kinase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase inhibits glycolysis, promotes hypertrophy, impairs myocyte function, and reduces insulin sensitivity. J Biol Chem 2004, 279(46):48085-48090.
46. Almeida A., Moncada S., Bolanos J.P. Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway. Nat Cell Biol 2004, 6(1):45-51.
47. Calvo M.N., Bartrons R., Castano E., Perales J.C., Navarro-Sabate A., Manzano A. PFKFB3 gene silencing decreases glycolysis, induces cell-cycle delay and inhibits anchorage-independent growth in HeLa cells. FEBS Lett 2006, 580(13):3308-3314.
48. Titolo D., Cai F., Belsham D.D. Coordinate regulation of neuropeptide Y and agouti-related peptide gene expression by estrogen depends on the ratio of estrogen receptor (ER) alpha to ER{beta} in clonal hypothalamic neurons. Mol Endocrinol 2006, 20(9):2080-2092.
49. Cai F., Gyulkhandanyan A.V., Wheeler M.B., Belsham D.D. Glucose regulates AMP-activated protein kinase activity and gene expression in clonal, hypothalamic neurons expressing proopiomelanocortin: additive effects of leptin or insulin. J Endocrinol 2007, 192(3):605-614.
50. Huo Y., Guo X., Li H., Xu H., Halim V., Zhang W., et al. Targeted overexpression of inducible 6-phosphofructo-2-kinase in adipose tissue increases fat deposition but protects against diet-induced insulin resistance and inflammatory responses. J Biol Chem 2012, 287(25):21492-21500.
51. Guo X., Li H., Xu H., Halim V., Zhang W., Wang H., et al. Palmitoleate induces hepatic steatosis but suppresses liver inflammatory response in mice. PLoS One 2012, 7(6):e39286.
52. Payne V.A., Arden C., Wu C., Lange A.J., Agius L. Dual role of phosphofructokinase-2/fructose bisphosphatase-2 in regulating the compartmentation and expression of glucokinase in hepatocytes. Diabetes 2005, 54(7):1949-1957.
53. Wu C., Okar D.A., Stoeckman A.K., Peng L., Herrera A.H., Herrera J.E., et al. A potential role for fructose-2,6-bisphosphate in the stimulation of hepatic glucokinase gene expression. Endocrinology 2004, 145(2):650-658.
54. Levin B.E. Neuronal glucose sensing: still a physiological orphan?. Cell Metab 2007, 6(4):252-254.
55. Kim E., Miller I., Aja S., Landree L.E., Pinn M., McFadden J., et al. C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase. J Biol Chem 2004, 279(19):19970-19976.
56. Mayer J. Glucostatic mechanism of regulation of food intake. N Engl J Med 1953, 249(1):13-16.
57. Mayer J. Regulation of energy intake and the body weight: the glucostatic theory and the lipostatic hypothesis. Ann N Y Acad Sci. 1955 Jul 15;63(1):15-43. 1955;63 (1):15-43.
58. Mobbs C.V., Isoda F., Makimura H., Mastaitis J., Mizuno T., Shu I.-W., et al. Impaired glucose signaling as a cause of obesity and the metabolic syndrome: the glucoadipostatic hypothesis. Physiol Behav 2005, 85(1):3-23.
59. Claret M., Smith M.A., Batterham R.L., Selman C., Choudhury A.I., Fryer L.G., et al. AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. J Clin Invest 2007, 117(8):2325-2336.